Dacarbazine, BCNU, cisplatin and tamoxifen (DBCT) v. dacarbazine and interferon (D/I) in advanced melanoma: interim results of a randomised phase III study

  • Middleton M
  • Lorigan P
  • Owen J
  • et al.
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Abstract

34th Annual Meeting of the American Society of Clinical Oncology; 16‐19 May 1998; Los Angeles, California, USA

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Middleton, M., Lorigan, P., Owen, J., Lee, S., Yip, D., Davies, J., … Thatcher, N. (1998). Dacarbazine, BCNU, cisplatin and tamoxifen (DBCT) v. dacarbazine and interferon (D/I) in advanced melanoma: interim results of a randomised phase III study. Proceedings of the American Society of Clinical Oncology, 17 CC-, 508a, Abstract 1958. Retrieved from https://www.cochranelibrary.com/central/doi/10.1002/central/CN-00692216/full

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

50%

Pharmacology, Toxicology and Pharmaceut... 1

50%

Save time finding and organizing research with Mendeley

Sign up for free